Cecelia Health announces the appointment of healthcare visionary, Brad Fleugel, as a Board Advisor. Brad was previously the SVP Chief Healthcare Commercial Market Development Officer for Walgreens, where he was responsible for all commercial healthcare activities. Previously, he was Chief Strategy and Business Development officer for Walgreens, responsible for corporate strategy and business development.
“The day I met Brad, I was immediately impressed with his strategic sense of the market and its landscape. And, with his stellar track record for driving strategic goals and measurable business results in leadership and strategic board roles at publicly-traded and private companies, we are very excited to have him contribute to our business plans,” said David Weingard, CEO of Cecelia Health. “Brad’s role on Cecelia Health’s Board of Advisors will significantly advance our ability to innovate and positively transform the lives and health outcomes of the patients we serve.”
“I’m excited to join Cecelia Health’s Board of Advisors and work with a leadership team that has demonstrated results in scaling personalized expert coaching and cost effectively driving measurable outcomes through the use of technology and unique data-driven insights,” said Brad Fluegel. “I see a big opportunity to extend the company’s innovative coaching model and product roadmap to further scale the number of lives they transform and the business results they drive for the health plan, pharmaceutical, medical device and other customers they work with.”